HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R L Schilsky Selected Research

eniluracil

4/2001Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma.
8/2000Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancer.
4/2000A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R L Schilsky Research Topics

Disease

12Neoplasms (Cancer)
10/2019 - 07/2000
8Colorectal Neoplasms (Colorectal Cancer)
10/2019 - 04/2000
3Lymphoma (Lymphomas)
06/2005 - 08/2000
1Neoplasm Metastasis (Metastasis)
03/2004
1Disease Progression
04/2002
1Diarrhea
04/2002
1Nausea
04/2002
1Sepsis (Septicemia)
04/2002
1Stomatitis
04/2002
1Fever (Fevers)
04/2002
1Alopecia (Baldness)
04/2002
1Neutropenia
04/2002
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2001
1Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2001
1Hepatocellular Carcinoma (Hepatoma)
09/2001
1Squamous Cell Carcinoma of Head and Neck
09/2001
1Mucositis
09/2001
1Carcinoma (Carcinomatosis)
09/2001
1Renal Cell Carcinoma (Grawitz Tumor)
09/2001
1Breast Neoplasms (Breast Cancer)
09/2000
1Fatigue
08/2000
1Anorexia
08/2000

Drug/Important Bio-Agent (IBA)

10Fluorouracil (Carac)FDA LinkGeneric
03/2004 - 04/2000
5Leucovorin (Folinic Acid)FDA Link
04/2002 - 04/2000
4Capecitabine (Xeloda)FDA Link
03/2004 - 09/2000
3eniluracilIBA
04/2001 - 04/2000
2Pharmaceutical PreparationsIBA
10/2019 - 05/2015
2BilirubinIBA
07/2003 - 08/2000
2Irinotecan (Camptosar)FDA LinkGeneric
01/2002 - 07/2001
1NivolumabIBA
10/2019
1Biomarkers (Surrogate Marker)IBA
05/2015
1Antisense OligonucleotidesIBA
06/2005
1GTI2040IBA
06/2005
1OligonucleotidesIBA
06/2005
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
06/2005
1RNA (Ribonucleic Acid)IBA
06/2005
1Messenger RNA (mRNA)IBA
06/2005
1thiamine triphosphorate (TTP)IBA
03/2004
1CreatinineIBA
07/2003
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2001
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2001
1GemcitabineFDA Link
09/2001
1CytokinesIBA
09/2001
1Cisplatin (Platino)FDA LinkGeneric
09/2001
1EmitefurIBA
08/2001
1ProdrugsIBA
08/2001
1TegafurIBA
08/2001
1UracilIBA
08/2001
16- ((2- (dimethylamino)ethyl)amino)- 3- hydroxy- 7H- indeno(2,1- c)quinolin- 7- oneIBA
04/2001
1EnzymesIBA
09/2000
1CarbamatesIBA
09/2000
1Paclitaxel (Taxol)FDA LinkGeneric
09/2000
1AnthracyclinesIBA
09/2000
1Thymidine PhosphorylaseIBA
09/2000
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2000
1doxifluridineIBA
09/2000
1Proteins (Proteins, Gene)FDA Link
08/2000
1O(6)-benzylguanineIBA
08/2000
1Carmustine (FIVB)FDA Link
08/2000
1Transaminases (Aminotransferases)IBA
08/2000
1Alkyl and Aryl TransferasesIBA
08/2000

Therapy/Procedure

7Therapeutics
10/2019 - 08/2000
2Drug Therapy (Chemotherapy)
08/2001 - 07/2000
1Immunotherapy
10/2019
1Precision Medicine
08/2015
1Intravenous Infusions
06/2005
1Combination Drug Therapy (Combination Chemotherapy)
09/2001
1TP protocol
09/2001